98 related articles for article (PubMed ID: 1552498)
1. Renin inhibitors containing alpha-heteroatom amino acids as P2 residues.
Repine JT; Kaltenbronn JS; Doherty AM; Hamby JM; Himmelsbach RJ; Kornberg BE; Taylor MD; Lunney EA; Humblet C; Rapundalo ST
J Med Chem; 1992 Mar; 35(6):1032-42. PubMed ID: 1552498
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors.
Patt WC; Hamilton HW; Taylor MD; Ryan MJ; Taylor DG; Connolly CJ; Doherty AM; Klutchko SR; Sircar I; Steinbaugh BA
J Med Chem; 1992 Jul; 35(14):2562-72. PubMed ID: 1635057
[TBL] [Abstract][Full Text] [Related]
3. Non-peptide renin inhibitors containing 2-(((3-phenylpropyl)phosphoryl)oxy)alkanoic acid moieties as P2-P3 replacements.
Raddatz P; Minck KO; Rippmann F; Schmitges CJ
J Med Chem; 1994 Feb; 37(4):486-97. PubMed ID: 8120867
[TBL] [Abstract][Full Text] [Related]
4. Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonate.
Repine JT; Himmelsbach RJ; Hodges JC; Kaltenbronn JS; Sircar I; Skeean RW; Brennan ST; Hurley TR; Lunney E; Humblet CC
J Med Chem; 1991 Jul; 34(7):1935-43. PubMed ID: 2066966
[TBL] [Abstract][Full Text] [Related]
5. Renin inhibitors containing a pyridyl amino diol derived C-terminus.
Heitsch H; Henning R; Kleemann HW; Linz W; Nickel WU; Ruppert D; Urbach H; Wagner A
J Med Chem; 1993 Sep; 36(19):2788-800. PubMed ID: 8410992
[TBL] [Abstract][Full Text] [Related]
6. Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.
Raddatz P; Jonczyk A; Minck KO; Rippmann F; Schittenhelm C; Schmitges CJ
J Med Chem; 1992 Sep; 35(19):3525-36. PubMed ID: 1404233
[TBL] [Abstract][Full Text] [Related]
7. New inhibitors of human renin that contain novel replacements at the P2 site.
Doherty AM; Kaltenbronn JS; Hudspeth JP; Repine JT; Roark WH; Sircar I; Tinney FJ; Connolly CJ; Hodges JC; Taylor MD
J Med Chem; 1991 Apr; 34(4):1258-71. PubMed ID: 1901910
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors.
Doherty AM; Sircar I; Kornberg BE; Quin J; Winters RT; Kaltenbronn JS; Taylor MD; Batley BL; Rapundalo SR; Ryan MJ
J Med Chem; 1992 Jan; 35(1):2-14. PubMed ID: 1732531
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of some transition-state inhibitors of human renin.
Bühlmayer P; Caselli A; Fuhrer W; Göschke R; Rasetti V; Rüeger H; Stanton JL; Criscione L; Wood JM
J Med Chem; 1988 Sep; 31(9):1839-46. PubMed ID: 3137345
[TBL] [Abstract][Full Text] [Related]
10. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
[TBL] [Abstract][Full Text] [Related]
11. Peptide analogues of angiotensinogen. Effect of peptide chain length on renin inhibition.
Plattner JJ; Greer J; Fung AK; Stein H; Kleinert HD; Sham HL; Smital JR; Perun TJ
Biochem Biophys Res Commun; 1986 Sep; 139(3):982-90. PubMed ID: 3533075
[TBL] [Abstract][Full Text] [Related]
12. Novel renin inhibitors containing (2S,3S,5S)-2-amino-1-cyclohexyl-6-methyl-3,5-heptanediol fragment as a transition-state mimic at the P1-P1' cleavage site.
Yamada Y; Ando K; Ikemoto Y; Tada H; Shirakawa E; Inagaki E; Shibata S; Nakamura I; Hayashi Y; Ikegami K; Uchida I
Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1631-41. PubMed ID: 9353891
[TBL] [Abstract][Full Text] [Related]
13. Acute hypotensive responses to peptide inhibitors of renin in conscious monkeys: an effect on blood pressure independent of plasma renin inhibition.
Schaffer LW; Schorn TW; Winquist RJ; Strouse JF; Payne L; Chakravarty PK; de Laszlo SE; tenBroeke J; Veber DF; Greenlee WJ
J Hypertens; 1990 Mar; 8(3):251-9. PubMed ID: 2159506
[TBL] [Abstract][Full Text] [Related]
14. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA
J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578
[TBL] [Abstract][Full Text] [Related]
15. Discovery of non-peptidic P2-P3 butanediamide renin inhibitors with high oral efficacy.
Simoneau B; Lavallée P; Anderson PC; Bailey M; Bantle G; Berthiaume S; Chabot C; Fazal G; Halmos T; Ogilvie WW; Poupart MA; Thavonekham B; Xin Z; Thibeault D; Bolger G; Panzenbeck M; Winquist R; Jung GL
Bioorg Med Chem; 1999 Mar; 7(3):489-508. PubMed ID: 10220035
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of novel imidazole alcohol inhibitors of primate renin.
DeForrest JM; Waldron TL; Oehl RS; Scalese RJ; Free CA; Weller HN; Ryono DE
J Hypertens Suppl; 1989 Apr; 7(2):S15-9. PubMed ID: 2666607
[TBL] [Abstract][Full Text] [Related]
17. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.
Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Umeyama H; Ishida T; Kiso Y
J Med Chem; 1990 Oct; 33(10):2707-14. PubMed ID: 2120440
[TBL] [Abstract][Full Text] [Related]
18. Substrate analogue renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites.
Raddatz P; Jonczyk A; Minck KO; Schmitges CJ; Sombroek J
J Med Chem; 1991 Nov; 34(11):3267-80. PubMed ID: 1956045
[TBL] [Abstract][Full Text] [Related]
19. 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivatives.
Bradbury RH; Major JS; Oldham AA; Rivett JE; Roberts DA; Slater AM; Timms D; Waterson D
J Med Chem; 1990 Sep; 33(9):2335-42. PubMed ID: 2118184
[TBL] [Abstract][Full Text] [Related]
20. Nonpeptide renin inhibitors employing a novel 3-aza(or oxa)-2,4-dialkyl glutaric acid moiety as a P2/P3 amide bond replacement.
Baker WR; Fung AK; Kleinert HD; Stein HH; Plattner JJ; Armiger YL; Condon SL; Cohen J; Egan DA; Barlow JL
J Med Chem; 1992 May; 35(10):1722-34. PubMed ID: 1588554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
